The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert ...

ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug ...

In this secondary analysis of the MINT trial, 30-day risks for the composite outcome of death and recurrent myocardial ...

For patients with acute myocardial infarction (MI) and anemia, 30-day risks for death or recurrent MI seem to increase with ...

The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert Consensus Statement on the Management of Patients with STEMI Referred for Primary ...

A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD.

A multicenter study led by Hospital Clínico San Carlos and the CNIC has validated a new preoperative planning method using ...

Early use of mechanical circulatory support did not reduce 6-month all-cause mortality. 2. MCS was associated with increased ...

A widowmaker heart attack affects the left anterior descending (LAD) artery. Read on to learn the effects and likelihood of ...

A multicenter study has described and validated a new strategy for guiding ablation procedures in patients with complex ...

Study compares immediate post-discharge care requirements for respiratory syncytial virus (RSV), influenza, acute myocardial ...

Myocardial Infarction, Cardiovascular Disease, Prevention, Challenges, Review Abdin, A. (2024) Myocardial Infarction and the Prevention Strategies Keeping it at Bay: A Narrative Review. Open Access ...